å»çæ©åšå ¬è¡šãããæŽå¯
ããŒã³ã»ã±ã¢ã»ããŒã±ãã â InsightsããŒã³ã±ã¢åžå Žã¯ãããŸããŸãªæè¡ã®é²æ©ãç®æãããã¹ãŠã®ç«å·ã®æ²»çã®ããã®æšæºçãªãœãªã¥ãŒã·ã§ã³ãšããŠç»å ŽããŸããã ããŒã³ã±ã¢ç®¡çã®æ £ç¿çãªå¯Ÿçã¯ãççŒå·å®³ã®ç®¡çã®ããã®åŸè ã®æå¹æ§ã®ããã«ãæ¥éã«å é²çãªè£œåãšäº€æãããŠããŸããããã«ãããããéãæ²»çããããšãã§ããŸãã ç«å·ã®å·å®³ã®åŠçœ®ã¯æ £ç¿çããã³é«åºŠã®å¿é ã®ãã¬ãã·ã³ã°ã®ãããªãããã¯ãã®ä»å ¥çæ³ãããŠäœ¿çšãå«ãã§ããŸãã é ãããŠããªãç«å·ã¯ãçæŽ»ã®è³ªã ãã§ãªããææçãå䜵çã®å±éºæ§ãé«ããã ãã§ãªããçæŽ»ã®è³ªãäœäžãããŸããã ãã®ãããçŒãã±ã¢ã¯æ²»çéçšã®éèŠãªéšåã§ãã ãŸãã... ãã£ãšèŠã
å®éšæ©åšåžå ŽèŠæš¡ãšäºæž¬ - 2026 - 2033ã°ããŒãã«ã©ãæ©åšåžå ŽèŠæš¡ã¯ã2026幎ã«12.7åç±³ãã«ã§è©äŸ¡ããã2033幎ãŸã§ã«21.9åç±³ãã«ã«éãããšäºæ³ããã2026幎ãã2033幎ãŸã§ã®8.1%ã®ååç©å¹Žéæé·ç(CAGR)ãå±ç€ºããŠããŸãããããã£ãŒã«ã°ããŒãã«ãªã©ãæ©åšåžå Žã¯ãå»çãå»è¬åããã€ãªãã¯ãããžãŒãããã³åŠè¡åéã«ãããç ç©¶ã蚺æãå質管çããã³ãã¹ãã§äœ¿çšãããæ©åšããã³ããã€ã¹ã§æ§æãããŠããŸãã åžå Žã¯ãç ç©¶éçºæŽ»åã®æ¡å€§ããã«ã¹ã±ã¢éèŠã®å¢å ãããã³èªååãããžã¿ã«ã©ããªã©ã®æè¡ã®é²æ©ã«ãã£ãŠäž»å°ãããå®å®ããæé·ãçµéšããŠããŸãã æ°èåœã«ãããç ç©¶ã€... ãã£ãšèŠã
ããã&ã³ãŒã«ãã»ã©ããŒããã¯åžå ŽèŠæš¡ãšäºæž¬ - 2026 - 2033äžççãªããããšã³ãŒã«ãã»ã©ããŒããã¯åžå Žã¯ã2026幎ãã2033幎ãŸã§ã®USD 1.42åã§è©äŸ¡ããããšæšå®ãããUSD 2.45åç±³ãã«ã«éãããšäºæ³ãããã ãã®æé·ã¯ãå é²ã®çµæžã®é«éœ¢åã代æ¿çæ³ã®æ®åã«ããæšé²ãããŠããŸãããããã£ãŒã«äžççãªããããšã³ãŒã«ãã»ã©ããŒããã¯åžå Žã¯ããã«ã¹ã±ã¢æ¯åºã®å¢å ãçéªšæ Œæ¡ä»¶ã®å¢å€§ãå é²å°åã§ã®äººå£ã®é«éœ¢åã«ãã£ãŠé§åãããå ç¢ãªæé·ãçµéšããŠããŸãã æé·ã®æè é䟵襲çãªçã¿ç®¡ç ãããŠã代æ¿çæ³ã¯ããã«éèŠãé«ããã äž»èŠãªãããã¯ãã¯ç é¢ãæž¡ãã²ã«ã®ããã¯ãå䜿çšå¯... ãã£ãšèŠã
骚移æ€ã¯ãæ¬ æéªšã®äº€æãå«ãå€ç§æè¡æé ã§ãã 骚移æ€ã骚移æ€ãåæéªšç§»æ€ãªã©ã®éªšç§»æ€ã®çš®é¡ã¯ãéªšç§»æ€æé ã§äœ¿çšãããŸãã ã»ã©ããã¯ã¹ãããªããŒããã€ãªã¢ã¯ãã£ãã¬ã©ã¹ãªã©ã®éªšç§»æ€ä»£æ¿åã®æ¡çšã®å¢å ãäºæ³ãããã 骚ç²é¬çããã³éªšç²é¬çã®ç¹æ§ãããéªšã®æ¥éªšã«äººéã®æé·å åã®å®è£ ã®æè¡ç鲿© demineralizedã®éªš ãããªã¯ã¹ã骚ã®åœ¢æ æ§ã¿ã³ãã¯è³ªãããã³è¡å°æ¿ã®è±å¯ãªè¡æŒ¿(PRP)ã¯ãåžå Žãã¬ã€ã€ãŒãäºæž¬æéã«ããã£ãŠäžççãªéªšã®ç§»æ€ããã³ä»£æ¿åžå Žã«ããã匷åãªäœçœ®ã確ç«ããããã®æé·æ©äŒãæäŸãããšäºæ³ãããŸããç ç©¶è ã¯ã骚ã®é¢é£éå®³ãæ²»çããããã®é©æ°çãªéªšç§»æ€ã®éçºã«çŠç¹ãåœãŠ... ãã£ãšèŠã
é¢ç¯é¡æ€æ»ããã€ã¹ åžå Ž â Insightsäœå éšåã蚺æã»æ²»çããããã®æé ã¯ãé¢ç¯çãšããŠç¥ãããŠãããæ€æ»ã«äœ¿çšããè£ çœ®ã¯é¢ç¯é¡æ€æ»è£ 眮ãšããŠç¥ãããŠããŸãã é¢ç¯é¡æ€æ»ã¯æå°éã®äŸµè¥²çåŠçœ®ã§ãããåéãéããŠå°ããªãããŒããã€ã³ãµãŒãããããšã«ãã£ãŠè¡ãããŸãã é¢ç¯é¡æ€æ»ã®äž»ãªå¿çšã¯ãäœã®å æ§é ã®èšºæã§ãã ååã瀺ãããã«ãå€ç§é¢ç¯é¡æ€æ»ã¯å€ç§çåŠçœ®ã®éã«ãããã®è£ 眮ã®äœ¿çšã§ãã é¢ç¯é¡æ€æ»ã¯ã骚ã®é害ãèãè©ãèã®é¢é£é害ãªã©ã®é¢ç¯ã®åé¡ãæ±ãããã«æŽåœ¢å€ç§å»åž«ã«ãã£ãŠåºã䜿çšãããŠããŸããé¢ç¯é¡æ€æ»è£ 眮ã«ã¯ãæ©æ¢°çæ©åšãé»åæ©åšã黿°æè¡æ©åšããããŒãããã³ããã·ã§ãŒããŒãé»... ãã£ãšèŠã
å©Šäººç§æ€æ»æ€ ååžå ŽèŠæš¡ãšäºæž¬ â 2026 â 2033äžççãªå©Šäººç§æ€æ»æ€ ååžå ŽèŠæš¡ã¯ã2026幎ã«1.2åç±³ãã«ã§è©äŸ¡ããã2033幎ãŸã§ã®8.1%ã®ååç©å¹Žéæé·ç(CAGR)ãå±ç€ºããUSD 2.03åãã«ã«éãããšäºæ³ãããããããã£ãŒã«å©Šäººç§ æ€æ»æ€ åã¯å©Šäººç§ã®ããã·ãŒãžã£ã®éã«æ °ããå®å šããã³ã¢ã¯ã»ã·ããªãã£ãæäŸããããã«èšèšãããŠããå°éã«ãããå»åŠã®å®¶å ·ã§ãã äž»èŠãªãããã¯ãã¯æåæ€ åãæ²¹å§æ€ åã黿°æ€ åããã³ã³ã³ããŒããã« ãã§ã¢ãåæäŸã®èª¿ç¯å¯èœãªé«ããåŸãããã³ããŸããŸãªæ€æ»ããã³åŠçœ®ãå容ããè¶³ãµããŒããå«ãã§ããŸãã é«åºŠã¢ãã«ã¯äººéå·¥åŠçã®èšèšãå¿è匷ãå奜ç... ãã£ãšèŠã
ã¹ããŒãããŒã å»çæ©åšåžå ŽèŠæš¡ãšäºæž¬ â 2026 â 2033ã°ããŒãã«ã¹ããŒãããŒã å»çæ©åšåžå ŽèŠæš¡ã¯ã2026幎ãã2033幎ãŸã§ã®USD 15.80åã§è©äŸ¡ããããšæšå®ãããUSD 35.40åç±³ãã«ã«éãããšäºæ³ãããããããã£ãŒã«ã¹ããŒãããŒã ã¡ãã£ã«ã«ããã€ã¹åžå Žã¯ãå¥åº·ç£èŠãšæ£è ã±ã¢ãå®¶åºã§é«ããããã«èšèšãããå¹ åºã補åãæäŸããŠããŸãã äž»èŠãªãããã¯ãã¯é éå¿è匷ãç£èŠè£ 眮ã身ã«ã€ããããå¥åº·ã®è¿œè·¡è ãã¹ããŒããªå«ãã§ããŸã è¡å§ã®ã¢ãã¿ãŒãã°ã«ã³ãŒã¹ã®ã¢ãã¿ãŒããã³èæã®ãªãã·ã¡ãŒã¿ã ããã«ãæ¥ç¶ãããæž©åºŠèšãã¹ããŒãåžå ¥åšãããŒã ECGè£ çœ®ãæ¡çšãããŠããŸãã ãã... ãã£ãšèŠã
æ£è æéè£ çœ®åžå Žã補åã¿ã€ãå¥ïŒç§»ååŒæ£è ãªããã倩äºãªããã座äœã»ç«äœããã³ç§»ä¹è£å©å ·ã暪移ä¹è£ 眮ãå ¥æµŽããã³ãã€ã¬çšãªãããéæ®µããã³åçŽç§»åæéã·ã¹ãã ïŒãæ£è ã®ç§»åã¬ãã«å¥ïŒå®å šã«èªç«ããæ£è ãéšåçã«äœéããããæ£è ãããã³æ©è¡å¯èœãªè»¢åãªã¹ã¯ã®é«ãæ£è ïŒãçšéå¥ïŒãããããæ€ åãžã®ç§»ä¹ãæ€ åãããã€ã¬ãžã®ç§»ä¹ãäœäœå€æïŒ ããããåŽæ¹ç§»éãå ¥æµŽããã³è¡çç§»éãããã³ç·æ¥ããã³è¥æºæ£è ãžã®ç§»é)ãèè·éå¥ (æšæºæ¥åãé«è忥åãè¥æºæ¥å)ã黿ºå¥ (æåãé»åããã€ããªãã)ããšã³ããŠãŒã¶ãŒå¥ (ç é¢ãé·æä»è·æœèšãåšå® å»çããªãããªããŒã·ã§ã³ ã»ã³ã¿ãŒã倿¥èšºçããã³èšºçæ)ãæµ... ãã£ãšèŠã
éŒæ²»çéåžå Žã補åã¿ã€ãå¥ïŒã¹ãã³ã¬ã¹éãééãééããã®ä»ã®ææïŒé ããã¿ã³ãªã©ïŒïŒãéãµã€ãºå¥ïŒçްéãäžéã倪éïŒãã³ãŒãã£ã³ã°å¥ïŒéã³ãŒãã£ã³ã°éããã³ã³ãŒãã£ã³ã°éïŒã·ãªã³ã³ã³ãŒãã£ã³ã°ããã©ã¹ããã¯ã³ãŒãã£ã³ã°ãªã©ïŒïŒããã¶ã€ã³å¥ïŒæåéã ããåŒéã黿°éŒïŒãçšéå¥ïŒåŸæ¥ã®éŒæ²»çã黿°éŒãè³ä»éŒãæå§ãããã³çŸå®¹éŒïŒããšã³ããŠãŒã¶ãŒå¥ïŒç é¢ãéŒçžé¢ãããŒã ã±ã¢æœèšããŠã§ã«ãã¹ã»ã³ã¿ãŒãçŒç管çã»ã³ã¿ãŒïŒãæµéãã£ãã«å¥ïŒãªã³ã©ã€ã³ããã³ãªãã©ã€ã³ïŒãå°çå¥ïŒåç±³ããšãŒããããã¢ãžã¢ïŒ 倪平æŽãã©ãã³ã¢ã¡ãªã«ãäžæ±ãã¢ããªã«)... ãã£ãšèŠã
ã¢ã«ã³ãŒã«ããã³è¬å€ã®è©Šéšè£ 眮ã¯ããã£ã®ã¢ã«ã³ãŒã«ãããŠè¬å€ã«ãã£ãŠåŒãèµ·ããããäžæ¯ã®ã¬ãã«ããã¹ãããã®ã«äœ¿çšãããŠããŸãã ã¢ã«ã³ãŒã«ããã³è¬ç©å«æéããã¹ãããããã«äœ¿çšãããæ©åšã®äžéšã«ã¯ãåŒåžåšãå°¿æ€æ»è£ 眮ãçµå£æ€æ»è£ 眮ãããã³ãã¢ãã¹ãè£ çœ®ãå ç«ã¢ãã»ã€åæè£ 眮ãããã³ã¯ãããã°ã©ãæ©åšãå«ãŸããŸããäžççãªã¢ã«ã³ãŒã«åŒåžåšããã³è¬å€ã®è©Šéšè£ 眮ã®åžå Žã¯è©äŸ¡ããããšæšå®ãããŸã US$5,215.4çŸäž ãåãåãã 2022幎 å±ç€ºäºå® ã«ã°ã¬ ã«ã€ã㊠6.3% äºå ±æéäž (2022-2030).å³1. ã°ããŒãã« ã¢ã«ã³ãŒã« åŒåžåšããã³è¬å€ã®è©Šéšè£ 眮ã®åžå Žã·ã§ã¢(%)ããš... ãã£ãšèŠã
ã°ããŒãã«å»ççšé žçŽ ã·ã¹ãã åžå Žååé žçŽ ã®ã³ã³ã»ã³ãã¬ã€ã¿ãŒããã³å§çž®ãããé žçŽ ã·ãªã³ããŒã®ãããªå»åŠã®é žçŽ ã·ã¹ãã ã¯ããŒã ã±ã¢ã®èšå®ã§äž»ã«äœ¿çšãããäž»ã«å¯åæ§ã§é£ããããããä¿¡é Œã§ããé žçŽ äŸçµŠã«äŸåããé«éœ¢è ã®æ£è ã«ãã£ãŠå¥œãŸããŸãã æ ¢æ§é塿§èºçŸæ£(COPD)ãæ ¢æ§æ°ç®¡æ¯çã emphysemaãå«ç ã®äžè¬çãªé·æå¹æã¯ã é žçŽ çæ³ ãŸãã¯ååãªé žçŽ ãåŸãããã«é žçŽ ãè£ãã é žçŽ ç³»ã¯ãé žçŽ ã®å¶åŸ¡éãæ£è ã«å±ããããã«äœ¿çšãããŸããäžççãªå»ççšé žçŽ ã·ã¹ãã åžå Žã§ã®ããŒã ã±ã¢èšå®ã»ã°ã¡ã³ãã¯ãå€§å¹ ãªåžå ŽäŸ¡å€ãç®æããããšãæåŸ ãããŸã, èã®äººå£ã®äžã§æ ¢æ§é塿§èºçŸæ£(COPD)ã®å¢æ®ã«å... ãã£ãšèŠã
ãã«ãŒã³ã«ããŒãã«ããŒã±ããã€ã³ãµã€ãæ°çã®ã«ããŒãã«ã¯ãã«ããŒãã«ãéè·¯ãäœæãããããŸãã¯æ¡å€§ããå Žæã«ãããšãèšè¹ããããããŸãã¯èšè¹ããããããããªããã®å ç«¯ã®æ°çãä»ããŠããé©çšç¯å²ãåºãè£ çœ®ã§ããããŸãå åèçŸæ£ã«ãã£ãŠåŒãèµ·ããããéå¡ãéããããã«äœ¿çšãããã ããã«ãæ°çã®ã«ããŒãã«ã¯è èã®denervationãcyoablationã§é©çšããæã£ãŠããŸã è¬ã®é é, çæµ, ãããŠãè§£ååŠ.2015幎ã«ããŒã財å£ãå ¬è¡šããçµ±èšã«ãããšãå åèçŸæ£ã¯ãç±³åœã®å¹Žéã§çŽ380,000ã®æ»äº¡çã«ã€ãªãããŸãããŸããåããœãŒã¹ã«ãããšãçŽ720,000人ã®äººã ãæ¯å¹Žå¿èçºäœã«èŠãã... ãã£ãšèŠã
ããŒãã«ããªãŒIVã³ãã¯ã¿ åžå Ž - Insightséã®ãªãIVã³ãã¯ã¿ã®ã¡ãŒã«ãŒã¯ãæ¶è²»è ã®ããã®é©æ°çãªè£œåã®éçºã«åŸäºããŠããŸãã BectonãDickinsonãCompanyãªã©ã®ã¡ãŒã«ãŒã¯ããªã¬ã³ãžè²ã®ã€ã³ãžã±ãŒã¿ãŒãåããNeutraClearããŒãã«ããªãŒã³ãã¯ã¿ãæäŸããã«ãŒã¢ãŒã«ãã誀ã£ãé€å»ãæžããããšãã§ããŸãã ãŸããICU Medical Inc.ã¯ãã³ãã¯ã¿ã®å€é¢ãšå éšé¢ã®æ¥è§Šãäœæžãããããã³ãã¯ã¿ãã·ãªã³ã³ã·ãŒã«ãããããŒãã«ããªãŒã³ãã¯ã¿ã®ç¬èªã®ç¹èš±æè¡ãæããçŽ°èæ±æãå€§å¹ ã«åæžããŸãã ã€ã³ããäžåœãã€ã³ããã·ã¢ãªã©ã®ã¢ãžã¢è«žåœã«ã¯ãéããªãŒIVã³ã... ãã£ãšèŠã
èŽèŠä¿è·ããã€ã¹åžå Ž - æŽå¯ èŽèŠä¿è·è£ 眮ã¯ãè³ã®å åŽãŸãã¯äžã«ããããã€ã¹ã§ããã€ãºèªçºã®é£èŽãé²ãããšãã§ããŸãã ã€ã€ãŒãããã€ã€ãŒãã©ã°ããã¢ãªã³ã°ãã³ããªã©ãããŸããŸãªçš®é¡ã®è£èŽåšããã€ã¹ããããŸãã ã€ã€ãŒããã¯ãè³ã®äžã«è£ çãããããã€ã¹ã§ãéšé³ã¬ãã«ãäœäžãããã€ã€ãŒãã©ã°ãè³ã«å·®ã蟌ã¿ãè³ã倧ããªéšé³ãæ°ŽäŸµå ¥ãç°ç©ãã»ããããŸãã¯é床ã®é¢šããä¿è·ããŸãã è³ã®ããã¯ç£æ¥ããã³è£œé æ¥ã®å Žæãé±å±±ã鳿¥œã³ã³ãµãŒããæŠäº(é²è¡ã»ã¯ã¿ãŒ)ããã³ä»ã®ã§äœ¿çšããããšãã§ããŸããã°ããŒãã«è£èŽåšåžå Žã¯ã2018幎ã®US $ 1,509.3çŸäžã§è©äŸ¡ãããäºæž¬æéã®11.6%ã®CAGRãç®... ãã£ãšèŠã
IV ããã°åžå Žã補åã¿ã€ãå¥ (PVC IV ããã°ãé PVC IV ããã°ãããã³ã«ã¹ã¿ã IV ããã°)ãææã¿ã€ãå¥ (ããªå¡©åããã« (PVC)ãããªãšãã¬ã³ (PE)ãããªãããã¬ã³ (PP)ãããã³ãšãã¬ã³é ¢é žããã« (EVA))ã容éå¥ (500 ml æªæºã500 ml ïœ 1000 mlãããã³ 1000 ml 以äž)ãçšéå¥ (ç¹æ»Žæ¶²ãæ é€ãæçç©è³ªãé»è§£è³ªãè¡æ¶²è£œå€ãããã³å®å šéçµå£æ é€ (TPN))ããšã³ããŠãŒã¶ãŒå¥ (ç é¢ã蚺çæã倿¥æè¡ã»ã³ã¿ãŒ (ASC)ãåšå® å»çãªã©)ãå°åå¥ (åç±³ããšãŒããããã¢ãžã¢å€ªå¹³æŽãã©ãã³ã¢ã¡ãªã«ãäžæ±ãããã³ã¢ããªã«)... ãã£ãšèŠã
EEGããã€ã¹åžå Ž â ã€ã³ãµã€ã 黿°è³é¡æ€æ»(EEG)ã¯è³å ã®é»æ°æŽ»åãèšæž¬ã»èšé²ããç¥çµåŠçæ€æ»ã§ãã ãã¹ãã¯ããŸããŸãªèšºæã§äœ¿çšãããŸã ç¥çµé害 粟ç¥ç ãããŒãã³ãœã³ç ãã¢ã«ããã€ããŒç ãªã©ã EEGã¢ãã¿ãªã³ã°ã¯ãå°å ã«ãããçºäœããã³æµè¡ã®èšºæã«ã䜿çšãããŸãã ã¹ã¿ã³ãã¢ããŒã³ãããŒã¿ãã«ãããã³ã¯ã€ã€ã¬ã¹ãªã©ã®EEG(Electroencephalography)ããã€ã¹ã®çš®é¡ã¯ç°ãªããŸããäžççãªãšã¬ã¯ãããšã³ã»ãã¡ãã°ã©ãã£ããã€ã¹åžå Žã¯ã US$ 2,198.0 ã¡ãŒãã« æ«å°Ÿã®å€ã®é¢ã§ 2027幎ãåãåããã°ããŒãã«EEGããã€ã¹åžå Ž:ãã©ã€ã㌠粟ç¥ç ãããŒãã³... ãã£ãšèŠã
èšåºè³ªéåæåžå Ž - æŽå¯ èšåºè³ªéåææ³ã¯ãç ç©¶ãå°éèšåºç ç©¶æãããã³ãã®æ¡çšã§åºãåãå ¥ããããŠããŸãã ã¬ã¹ã¯ãããã°ã©ãã£ãŒ(GC)ãŸãã¯æ¶²äœã¯ãããã°ã©ãã£ãŒ(LC)ã«ãã質éåææ³ã®çµã¿åããã¯ããã®æè¡ã®æ¥éãªæ¡å€§ã«è²¢ç®ããŠããŸãã 質éåææ³(MS)ã¯ãæ²»çè¬ã®ç£èŠãèåŸ ã®è¬ãããã³èšåºæ¯æ§åŠãªã©ã®å€ãã®èšåºé åã§ã¢ããªã±ãŒã·ã§ã³ãæã£ãŠããŸããèšåºè³ªéåææ³ã¯ãéååç©ã®ç¹å®ããã³ãã®é©åã®è©³çްãªã©ã®å»è¬åéçºã®ãã¹ãŠã®ãã§ãŒãºã«ãããè€éãªæ··åç©ã®è©äŸ¡ã®ããã®å®éçããã³å®æ§åæããŒã«ãšããŠæ©èœããŸãã èšåºç ç©¶æã¯ããããªãã¯ã¹æ¯æŽã¬ãŒã¶ãŒè±ç/ã€ãªã³å(MALDI-T... ãã£ãšèŠã
ã°ããŒãã«ãªã¹ãããŒææ°Žããã°åžå Ž â ããŒã±ããã€ã³ãµã€ãOstomyã¯ã身äœã®å éšã«ååšãã屿ããã®éå£éšãŸãã¯stomaãäœæããããã«è¡ãããæè¡ã§ãã ããã¯äž»ã«å°¿ãŸãã¯æ¶ååšç³»ã«é¢é£ããçŸæ£ãæ±ããŸãã Ostomyã¯æ°žä¹ çãªãããŸãã¯äžæçãªããå ŽåããããŸãã äžéšã®ã±ãŒã¹ã§ã¯ãèåšã®æ°žä¹ çãªå¥é¢ãŸãã¯é€å»ãå¿ èŠã§ããç³å°¿ç ããã³æ¶ååšçŸæ£ããã³è èç (NIDDK)ã®åœç«ç ç©¶æã«ãããšããªã¹ããã€ã¢ã¯ãã€ãã¹ãããŒãã³ãã¹ããã€ãããã³ãŠãã¹ããã€ãšãã3ã€ã®ã¿ã€ãã«åºãåããããŸãã ã€ã¬ãªã¹ãããŒã§ã¯ãã€ã©ã ãŸãã¯å°è žã®ããŒã¹ãéå£éšãŸãã¯ã¹ããã«åãä»ããããŸãã ãã... ãã£ãšèŠã